Skip to main content Accessibility help
×
×
Home

‘The way to a man's heart is through his gut microbiota’ – dietary pro- and prebiotics for the management of cardiovascular risk

  • Kieran M. Tuohy (a1), Francesca Fava (a1) and Roberto Viola (a1)
Abstract

The human gut microbiota has been identified as a possible novel CVD risk factor. This review aims to summarise recent insights connecting human gut microbiome activities with CVD and how such activities may be modulated by diet. Aberrant gut microbiota profiles have been associated with obesity, type 1 and type 2 diabetes and non-alcoholic fatty liver disease. Transfer of microbiota from obese animals induces metabolic disease and obesity in germ-free animals. Conversely, transfer of pathogen-free microbiota from lean healthy human donors to patients with metabolic disease can increase insulin sensitivity. Not only are aberrant microbiota profiles associated with metabolic disease, but the flux of metabolites derived from gut microbial metabolism of choline, phosphatidylcholine and l-carnitine has been shown to contribute directly to CVD pathology, providing one explanation for increased disease risk of eating too much red meat. Diet, especially high intake of fermentable fibres and plant polyphenols, appears to regulate microbial activities within the gut, supporting regulatory guidelines encouraging increased consumption of whole-plant foods (fruit, vegetables and whole-grain cereals), and providing the scientific rationale for the design of efficacious prebiotics. Similarly, recent human studies with carefully selected probiotic strains show that ingestion of viable microorganisms with the ability to hydrolyse bile salts can lower blood cholesterol, a recognised risk factor in CVD. Taken together such observations raise the intriguing possibility that gut microbiome modulation by whole-plant foods, probiotics and prebiotics may be at the base of healthy eating pyramids advised by regulatory agencies across the globe. In conclusion, dietary strategies which modulate the gut microbiota or their metabolic activities are emerging as efficacious tools for reducing CVD risk and indicate that indeed, the way to a healthy heart may be through a healthy gut microbiota.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      ‘The way to a man's heart is through his gut microbiota’ – dietary pro- and prebiotics for the management of cardiovascular risk
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      ‘The way to a man's heart is through his gut microbiota’ – dietary pro- and prebiotics for the management of cardiovascular risk
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      ‘The way to a man's heart is through his gut microbiota’ – dietary pro- and prebiotics for the management of cardiovascular risk
      Available formats
      ×
Copyright
Corresponding author
* Corresponding author: K. M. Tuohy, fax 0039 0461 615200, email kieran.tuohy@fmach.it
References
Hide All
1. Gensini, GF, Comeglio, M & Colella, A (1988) Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J 19, Suppl. A, A53A61.
2. Negi, S & Anand, A (2010) Atherosclerotic coronary heart disease-epidemiology, classification and management. Cardiovasc Hematol Disord Drug Targets 10, 257261.
3. Ley, RE, Turnbaugh, PJ, Klein, S et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 10221023.
4. Giongo, A, Gano, KA, Crabb, DB et al. (2011) Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 5, 8291.
5. Brown, CT, Davis-Richardson, AG, Giongo, A et al. (2011) Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 6, e25792.
6. de Goffau, MC, Luopajärvi, K, Knip, M et al. (2013) Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 62, 12381244.
7. Larsen, N, Vogensen, FK, van den Berg, FW et al. (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5, e9085.
8. Zhu, L, Baker, SS, Gill, C et al. (2013) Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57, 601609.
9. Sanapareddy, N, Legge, RM, Jovov, B et al. (2012) Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J 6, 18581868.
10. Markle, JG, Frank, DN, Mortin-Toth, S et al. (2013) Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 10841088.
11. Bäckhed, F, Ding, H, Wang, T et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101, 1571815723.
12. Vrieze, A, Van Nood, E, Holleman, F et al. (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913916.e7.
13. Wang, Z, Klipfell, E, Bennett, BJ et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 5763.
14. Koeth, RA, Wang, Z, Levison, BS et al. (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19, 576585.
15. Conterno, L, Fava, F, Viola, R et al. (2011) Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr 6, 241260.
16. Cani, PD, Amar, J, Iglesias, MA et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 17611772.
17. Zhang, C, Zhang, M, Wang, S et al. (2010) Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 4, 232241.
18. Fava, F, Gitau, R, Griffin, BA et al. (2013) The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ‘at-risk’ population. Int J Obes (Lond) 37, 216223.
19. Cani, PD, Neyrinck, AM, Fava, F et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 23742383.
20. Arora, T, Loo, RL, Anastasovska, J et al. (2012) Differential effects of two fermentable carbohydrates on central appetite regulation and body composition. PLoS ONE 7, e43263.
21. Anastasovska, J, Arora, T, Sanchez Canon, GJ et al. (2012) Fermentable carbohydrate alters hypothalamic neuronal activity and protects against the obesogenic environment. Obesity (Silver Spring) 20, 10161023.
22. Tuohy, KM, Brown, DT & Klinder, A (2010) Shaping the human microbiome with prebiotic foods – current perspectives for continued development. Food Sci Technol Bull: Funct Foods 7, 4964.
23. Wolever, TM (1997) Workshop report. Fiber and CHD management. Adv Exp Med Biol 427, 315317.
24. Delzenne, NM & Williams, CM (2002) Prebiotics and lipid metabolism. Curr Opin Lipidol 13, 6167.
25. Jenkins, DJ, Kendall, CW, Axelsen, M et al. (2000) Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease. Curr Opin Lipidol 11, 4956.
26. Fava, F, Lovegrove, JA, Gitau, R et al. (2006) The gut microbiota and lipid metabolism: implications for human health and coronary heart disease. Curr Med Chem 13, 30053021.
27. Toeller, M, Buyken, AE, Heitkamp, G et al. (1999) Fiber intake, serum cholesterol levels, and cardiovascular disease in European individuals with type 1 diabetes. EURODIAB IDDM Complications Study Group. Diabetes Care 22, Suppl. 2, B21B28.
28. Ludwig, DS, Pereira, MA, Kroenke, CH et al. (1999) Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 282, 15391546.
29. Jones, ML, Martoni, CJ, Parent, M et al. (2012) Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr 107, 15051513.
30. Jones, ML, Martoni, CJ & Prakash, S (2012) Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Eur J Clin Nutr 66, 12341241.
31. Tuohy, KM, Gougoulias, C, Shen, Q et al. (2009) Studying the human gut microbiota in the trans-omics era – focus on metagenomics and metabonomics. Curr Pharm Des 15, 14151427.
32. Flint, HJ, Scott, KP, Louis, P et al. (2012) The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 9, 577589.
33. Lepage, P, Leclerc, MC, Joossens, M et al. (2013) A metagenomic insight into our gut's microbiome. Gut 62, 146158.
34. Ouwehand, A, Isolauri, E & Salminen, S (2002) The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr 41, Suppl. 1, I32I37.
35. Fava, F & Danese, S (2011) Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 17, 557566.
36. Mulder, IE, Schmidt, B, Lewis, M et al. (2011) Restricting microbial exposure in early life negates the immune benefits associated with gut colonization in environments of high microbial diversity. PLoS ONE 6, e28279.
37. Hand, T & Belkaid, Y (2010) Microbial control of regulatory and effector T cell responses in the gut. Curr Opin Immunol 22, 6372.
38. Zhou, P, Ten, S, Sinha, S et al. (2008) Insulin receptor autoimmunity and insulin resistance. J Pediatr Endocrinol Metab 21, 369375.
39. Nokoff, N & Rewers, M (2013) Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals. Ann N Y Acad Sci 1281, 115.
40. Carbone, F, Nencioni, A, Mach, F et al. (2013) Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases. Thromb Haemost 109, 854868.
41. Fetissov, SO, Hamze Sinno, M, Coëffier, M et al. (2008) Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition 24, 348359.
42. Proal, AD, Albert, PJ & Marshall, T (2009) Autoimmune disease in the era of the metagenome. Autoimmun Rev 8, 677681.
43. Gill, SR, Pop, M, Deboy, RT et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science 312, 13551359.
44. Clifford, MN (2004) Diet-derived phenols in plasma and tissues and their implications for health. Planta Med 70, 11031114.
45. Lu, MF, Xiao, ZT & Zhang, HY (2013) Where do health benefits of flavonoids come from? Insights from flavonoid targets and their evolutionary history. Biochem Biophys Res Commun 434, 701704.
46. Tzounis, X, Rodriguez-Mateos, A, Vulevic, J et al. (2011) Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr 93, 6272.
47. Queipo-Ortuño, MI, Boto-Ordóñez, M, Murri, M et al. (2012) Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr 95, 13231334.
48. Natella, F, Macone, A, Ramberti, A et al. (2011) Red wine prevents the postprandial increase in plasma cholesterol oxidation products: a pilot study. Br J Nutr 105, 17181723.
49. Petschow, B, Doré, J, Hibberd, P et al. (2013) Probiotics, prebiotics, and the host microbiome: the science of translation. Ann N Y Acad Sci 1306, 117.
50. Willcox, DC, Willcox, BJ, Todoriki, H et al. (2009) The Okinawan diet: health implications of a low-calorie, nutrient-dense, antioxidant-rich dietary pattern low in glycemic load. J Am Coll Nutr 28, Suppl., 500S516S.
51. Moore, WE & Holdeman, LV (1974) Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 27, 961979.
52. Koornhof, HJ, Richardson, NJ, Wall, DM et al. (1979) Fecal bacteria in South African rural blacks and other population groups. Isr J Med Sci 15, 335340.
53. Benno, Y, Suzuki, K, Suzuki, K et al. (1986) Comparison of the fecal microflora in rural Japanese and urban Canadians. Microbiol Immunol 30, 521532.
54. Moore, WE & Moore, LH (1995) Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 61, 32023207.
55. De Filippo, C, Cavalieri, D, Di Paola, M et al. (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107, 1469114696.
56. Schwiertz, A, Taras, D, Schäfer, K et al. (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18, 190195.
57. Borthakur, A, Priyamvada, S, Kumar, A et al. (2012) A novel nutrient sensing mechanism underlies substrate-induced regulation of monocarboxylate transporter-1. Am J Physiol Gastrointest Liver Physiol 303, G1126G1133.
58. Gonçalves, P, Catarino, T, Gregório, I et al. (2012) Inhibition of butyrate uptake by the primary bile salt chenodeoxycholic acid in intestinal epithelial cells. J Cell Biochem 113, 29372947.
59. Teixeira, TF, Grześkowiak, Ł, Franceschini, SC et al. (2013) Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors. Br J Nutr 109, 914919.
60. Yatsunenko, T, Rey, FE, Manary, MJ et al. (2012) Human gut microbiome viewed across age and geography. Nature 486, 222227.
61. U.S. Department of Agriculture and U.S. Department of Health and Human Services (2012) Dietary guidelines for Americans. http://www.cnpp.usda.gov/Publications/DietaryGuidelines/2010/PolicyDoc/PolicyDoc.pdf
62. Food Standards Agency, U.K. (2011) Eat Well Plate. http://www.food.gov.uk/scotland/scotnut/eatwellplate/
63. Jacobs, DR Jr, Meyer, KA, Kushi, LH et al. (1999) Is whole grain intake associated with reduced total and cause-specific death rates in older women? The Iowa Women's Health Study. Am J Public Health 89, 322329.
64. Liu, S, Manson, JE, Lee, IM et al. (2000) Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. Am J Clin Nutr 72, 922928.
65. Joshipura, KJ, Hu, FB, Manson, JE et al. (2001) The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 134, 11061114.
66. Mellen, PB, Walsh, TF, Herrington, DM (2008) Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis 18, 283290.
67. He, M, van Dam, RM, Rimm, E et al. (2010) Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus. Circulation 121, 21622168.
68. Ye, EQ, Chacko, SA, Chou, EL et al. (2012) Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr 142, 13041313.
69. European Food Safety Authority (2010) Scientific opinion on establishing food-based dietary guidelines. EFSA J 8:1460 [42 pp.]. http://www.efsa.europa.eu/en/efsajournal/pub/1460.htm
70. Del Rio, D, Rodriguez-Mateos, A, Spencer, JP et al. (2013) Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 18, 18181892.
71. Costabile, A, Klinder, A, Fava, F et al. (2008) Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br J Nutr 99, 110120.
72. Lin, HV, Frassetto, A, Kowalik, EJ Jr et al. (2012) Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 7, e35240.
73. Tappenden, KA, Albin, DM, Bartholome, AL et al. (2003) Glucagon-like peptide-2 and short-chain fatty acids: a new twist to an old story. J Nutr 133, 37173720.
74. Cani, PD, Possemiers, S, Van de Wiele, T et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 10911103.
75. Xiong, Y, Miyamoto, N, Shibata, K et al. (2004) Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci USA 101, 10451050.
76. Al-Lahham, S, Roelofsen, H, Rezaee, F et al. (2012) Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects. Eur J Clin Invest 42, 357364.
77. Gao, Z, Yin, J, Zhang, J et al. (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 15091517.
78. Jones, BV, Begley, M, Hill, C et al. (2008) Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci USA 105, 1358013585.
79. Jones, ML, Tomaro-Duchesneau, C, Martoni, CJ et al. (2013) Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications. Expert Opin Biol Ther 13, 631642.
80. Charach, G, Grosskopf, I, Rabinovich, A et al. (2011) The association of bile acid excretion and atherosclerotic coronary artery disease. Therap Adv Gastroenterol 4, 95101.
81. Matsubara, T, Li, F & Gonzalez, FJ (2013) FXR signaling in the enterohepatic system. Mol Cell Endocrinol 368, 1729.
82. Kay, RM & Truswell, AS (1977) Effect of citrus pectin on blood lipids and fecal steroid excretion in man. Am J Clin Nutr 30, 171175.
83. Marlett, JA, Hosig, KB, Vollendorf, NW et al. (1994) Mechanism of serum cholesterol reduction by oat bran. Hepatology 20, 14501457.
84. Sembries, S, Dongowski, G, Mehrländer, K et al. (2006) Physiological effects of extraction juices from apple, grape, and red beet pomaces in rats. J Agric Food Chem 54, 1026910280.
85. Cyphert, HA, Ge, X, Kohan, AB et al. (2012) Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21. J Biol Chem 287, 2512325138.
86. Li, F, Patterson, AD, Krausz, KW et al. (2012) Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis. J Lipid Res 53, 16251635.
87. Watanabe, M, Morimoto, K, Houten, SM et al. (2012) Bile acid binding resin improves metabolic control through the induction of energy expenditure. PLoS ONE 7, e38286.
88. Sayin, SI, Wahlström, A, Felin, J et al. (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17, 225235.
89. Barrett, E, Ross, RP, O'Toole, PW et al. (2012) γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 113, 411417.
90. Tian, J, Dang, HN, Yong, J et al. (2011) Oral treatment with γ-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice. PLoS ONE 6, e25338.
91. D'Aimmo, MR, Mattarelli, P, Biavati, B et al. (2012) The potential of bifidobacteria as a source of natural folate. J Appl Microbiol 112, 975984.
92. Pompei, A, Cordisco, L, Amaretti, A et al. (2007) Administration of folate-producing bifidobacteria enhances folate status in Wistar rats. J Nutr 137, 27422746.
93. Wall, R, Ross, RP, Shanahan, F et al. (2009) Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. Am J Clin Nutr 89, 13931401.
94. Wall, R, Ross, RP, Shanahan, F et al. (2010) Impact of administered bifidobacterium on murine host fatty acid composition. Lipids 45, 429436.
95. Tricon, S, Burdge, GC, Williams, CM et al. (2005) The effects of conjugated linoleic acid on human health-related outcomes. Proc Nutr Soc 64, 171182.
96. Pfeuffer, M, Fielitz, K, Laue, C et al. (2011) CLA does not impair endothelial function and decreases body weight as compared with safflower oil in overweight and obese male subjects. J Am Coll Nutr 30, 1928.
97. al-Waiz, M, Mikov, M, Mitchell, SC et al. (1992) The exogenous origin of trimethylamine in the mouse. Metabolism 41, 135136.
98. Koteish, A & Mae Diehl, A (2002) Animal models of steatohepatitis. Best Pract Res Clin Gastroenterol 16, 7990.
99. Dumas, ME, Barton, RH, Toye, A et al. (2006) Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 103, 1251112516.
100. Deplancke, B, Finster, K, Graham, WV et al. (2003) Gastrointestinal and microbial responses to sulfate-supplemented drinking water in mice. Exp Biol Med (Maywood) 228, 424433.
101. Carbonero, F, Benefiel, AC & Gaskins, HR (2012) Contributions of the microbial hydrogen economy to colonic homeostasis. Nat Rev Gastroenterol Hepatol 9, 504518.
102. Craciun, S & Balskus, EP (2012) Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci USA 109, 2130721312.
103. Gibson, GR, Cummings, JH & Macfarlane, GT (1988) Competition for hydrogen between sulphate-reducing bacteria and methanogenic bacteria from the human large intestine. J Appl Bacteriol 65, 241247.
104. Fernandes, J, Wang, A, Su, W et al. (2013) Age, dietary fiber, breath methane, and fecal short chain fatty acids are interrelated in archaea-positive humans. J Nutr 143, 12691275.
105. Christl, SU, Gibson, GR & Cummings, JH (1992) Role of dietary sulphate in the regulation of methanogenesis in the human large intestine. Gut 33, 12341238.
106. Christl, SU, Murgatroyd, PR, Gibson, GR et al. (1992) Production, metabolism, and excretion of hydrogen in the large intestine. Gastroenterology 102, 12691277.
107. Mills, DJ, Tuohy, KM, Booth, J et al. (2008) Dietary glycated protein modulates the colonic microbiota towards a more detrimental composition in ulcerative colitis patients and non-ulcerative colitis subjects. J Appl Microbiol 105, 706714.
108. Kerr, BJ, Weber, TE, Ziemer, CJ et al. (2011) Effect of dietary inorganic sulfur level on growth performance, fecal composition, and measures of inflammation and sulfate-reducing bacteria in the intestine of growing pigs. J Anim Sci 89, 426437.
109. Khalil, NA, Walton, GE, Gibson, GR et al. (2013) In vitro batch cultures of gut microbiota from healthy and ulcerative colitis (UC) subjects suggest that sulphate-reducing bacteria levels are raised in UC and by a protein-rich diet. Int J Food Sci Nutr (Epublication ahead of print).
110. Bernstein, AM, Sun, Q, Hu, FB et al. (2010) Major dietary protein sources and risk of coronary heart disease in women. Circulation 122, 876883.
111. Micha, R, Michas, G & Mozaffarian, D (2012) Unprocessed red and processed meats and risk of coronary artery disease and type 2 diabetes – an updated review of the evidence. Curr Atheroscler Rep 14, 515524.
112.Joint FAO/WHO Working Group report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada (2002). http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf
113. Tuohy, KM, Probert, HM, Smejkal, CW et al. (2003) Using probiotics and prebiotics to improve gut health. Drug Discov Today 8, 692700.
114. Hepner, G, Fried, R, St Jeor, S et al. (1979) Hypocholesterolemic effect of yogurt and milk. Am J Clin Nutr 32, 1924.
115. Mann, GV, Spoerry, A, Gray, M et al. (1972) Atherosclerosis in the Masai. Am J Epidemiol 95, 2637.
116. Rossouw, JE, Burger, EM, Van der Vyver, P et al. (1981) The effect of skim milk, yoghurt, and full cream milk on human serum lipids. Am J Clin Nutr 34, 351356.
117. Anderson, JW & Gilliland, SE (1999) Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr 18, 4350.
118. Bertolami, MC, Faludi, AA & Batlouni, M (1999) Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur J Clin Nutr 53, 97101.
119. Simons, LA, Amansec, SG & Conway, P (2006) Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr Metab Cardiovasc Dis 16, 531535.
120. Ataie-Jafari, A, Larijani, B, Alavi Majd, H et al. (2009) Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann Nutr Metab 54, 2227.
121. Karlsson, C, Ahrné, S, Molin, G et al. (2010) Probiotic therapy to men with incipient arteriosclerosis initiates increased bacterial diversity in colon: a randomized controlled trial. Atherosclerosis 208, 228233.
122. Ejtahed, HS, Mohtadi-Nia, J, Homayouni-Rad, A et al. (2011) Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 94, 32883294.
123. Fuentes, MC, Lajo, T, Carrión, JM et al. (2013) Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults. Br J Nutr 109, 18661872.
124. Agerholm-Larsen, L, Bell, ML, Grunwald, GK et al. (2000) The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Eur J Clin Nutr 54, 856860.
125. Hlivak, P, Odraska, J, Ferencik, M et al. (2005) One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels. Bratisl Lek Listy 106, 6772.
126. Rees, K, Hartley, L, Day, C et al. (2013) Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 31, CD009671.
127. Jackson, K & Lovegrove, J (2013) Impact of probiotics, prebiotico and synbiotics on lipid metabolism in humans. Nutr Aging 1, 181200.
128. Pereira, DI & Gibson, GR (2002) Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37, 259281.
129. Gibson, GR & Roberfroid, MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 14011412.
130. Delzenne, NM, Daubioul, C, Neyrinck, A et al. (2002) Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects. Br J Nutr 87, Suppl. 2, S255S259.
131. Slavin, J (2004) Whole grains and human health. Nutr Res Rev 17, 99110.
132. Brighenti, F (2007) Dietary fructans and serum triacylglycerols: a meta-analysis of randomized controlled trials. J Nutr 137, 11 Suppl., 2552S2556S.
133. Brighenti, F, Casiraghi, MC, Canzi, E et al. (1999) Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur J Clin Nutr 53, 726733.
134. Luo, J, Rizkalla, SW, Alamowitch, C et al. (1996) Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr 63, 939945.
135. Pedersen, A, Sandström, B & Van Amelsvoort, JM (1997) The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr 78, 215222.
136. Kruse, HP, Kleessen, B & Blaut, M (1999) Effects of inulin on faecal bifidobacteria in human subjects. Br J Nutr 82, 375382.
137. van Dokkum, W, Wezendonk, B, Srikumar, TS et al. (1999) Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 53, 17.
138. Jackson, KG, Taylor, GR, Clohessy, AM et al. (1999) The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr 82, 2330.
139. Causey, JL, Feirtag, JM, Gallager, DD et al. (2000) Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nutr Res 20, 191201.
140. Letexier, D, Diraison, F & Beylot, M (2003) Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J Clin Nutr 77, 559564.
141. Russo, F, Chimienti, G, Riezzo, G et al. (2008) Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers. Eur J Nutr 47, 453459.
142. Forcheron, F & Beylot, M (2007) Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans. Metabolism 56, 10931098.
143. Vulevic, J, Drakoularakou, A, Yaqoob, P et al. (2008) Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 88, 14381446.
144. Yen, CH, Kuo, YW, Tseng, YH et al. (2011) Beneficial effects of fructo-oligosaccharides supplementation on fecal bifidobacteria and index of peroxidation status in constipated nursing-home residents – a placebo-controlled, diet-controlled trial. Nutrition 27, 323328.
145. Hidaka, H, Hirayama, M, Tokunaga, T et al. (1990) The effects of undigestible fructooligosaccharides on intestinal microflora and various physiological functions on human health. Adv Exp Med Biol 270, 105117.
146. Davidson, MH, Maki, KC, Synecki, C et al. (1998) Effects of dietary inulin on serum lipids in men and women with hypercholesterolemia. Nutr Res 18, 503517.
147. Giacco, R, Clemente, G, Luongo, D et al. (2004) Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin Nutr 23, 331340.
148. Yamashita, K, Kawai, K & Itakura, M (1984) Effects of fructooligosaccharides on blood-glucose and serum-lipids in diabetic subjects. Nutr Res 4, 961966.
149. Alles, MS, de Roos, NM, Bakx, JC et al. (1999) Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am J Clin Nutr 69, 6469.
150. Balcázar-Muñoz, BR, Martínez-Abundis, E & González-Ortiz, M (2003) Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia. Rev Med Chil 131, 597604.
151. Genta, S, Cabrera, W, Habib, N et al. (2009) Yacon syrup: beneficial effects on obesity and insulin resistance in humans. Clin Nutr 28, 182187.
152. Vulevic, J, Juric, A, Tzortzis, G et al. (2013) A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 143, 324331.
153. Demigné, C, Morand, C, Levrat, MA et al. (1995) Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br J Nutr 74, 209219.
154. Kok, NN, Morgan, LM, Williams, CM et al. (1998) Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats. J Nutr 128, 10991103.
155. Everard, A, Belzer, C, Geurts, L et al. (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110, 90669071.
156. Reagan-Shaw, S, Nihal, M & Ahmad, N (2008) Dose translation from animal to human studies revisited. FASEB J 22, 659661.
157. Ryan, D, Kendall, M & Robards, K (2007) Bioactivity of oats as it relates to cardiovascular disease. Nutr Res Rev 20, 147162.
158. Borneo, R & León, AE (2012) Whole grain cereals: functional components and health benefits. Food Funct 3, 110119.
159. Tiwari, U & Cummins, E (2011) Meta-analysis of the effect of β-glucan intake on blood cholesterol and glucose levels. Nutrition 27, 10081016.
160.Scientific Opinion on the substantiation of a health claim related to oat beta glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006. http://www.efsa.europa.eu/de/efsajournal/pub/1885.htm
161. Gunness, P & Gidley, MJ (2010) Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides. Food Funct 1, 149155.
162. Andersson, KE, Axling, U, Xu, J et al. (2012) Diverse effects of oats on cholesterol metabolism in C57BL/6 mice correlate with expression of hepatic bile acid-producing enzymes. Eur J Nutr 52, 17551759.
163. Hughes, SA, Shewry, PR, Gibson, GR et al. (2008) In vitro fermentation of oat and barley derived beta-glucans by human faecal microbiota. FEMS Microbiol Ecol 64, 482493.
164. Kim, HJ & White, PJ (2009) In vitro fermentation of oat flours from typical and high beta-glucan oat lines. J Agric Food Chem 57, 75297536.
165. Nordlund, E, Aura, AM, Mattila, I et al. (2012) Formation of phenolic microbial metabolites and short-chain fatty acids from rye, wheat, and oat bran and their fractions in the metabolical in vitro colon model. J Agric Food Chem 60, 81348145.
166. Connolly, ML, Lovegrove, JA & Tuohy, KM (2010) In vitro evaluation of the microbiota modulation abilities of different sized whole oat grain flakes. Anaerobe 16, 483488.
167. Connolly, ML, Tuohy, KM & Lovegrove, JA (2012) Wholegrain oat-based cereals have prebiotic potential and low glycaemic index. Br J Nutr 108, 21982206.
168. Psichas, A, Little, T, Lal, S et al. (2012) Colestyramine slows gastric emptying of liquids and reduces appetite in healthy subjects. Neurogastroenterol Motil 24, 10951101.
169. Ooi, LG, Ahmad, R, Yuen, KH et al. (2010) Lactobacillus gasseri [corrected] CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters. J Dairy Sci 93, 50485058.
170. Tanaka, H, Doesburg, K, Iwasaki, T et al. (1999) Screening of lactic acid bacteria for bile salt hydrolase activity. J Dairy Sci 82, 25302535.
171. Kim, GB, Yi, SH & Lee, BH (2004) Purification and characterization of three different types of bile salt hydrolases from Bifidobacterium strains. J Dairy Sci 87, 258266.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Proceedings of the Nutrition Society
  • ISSN: 0029-6651
  • EISSN: 1475-2719
  • URL: /core/journals/proceedings-of-the-nutrition-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed